Cardiff Oncology
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $165 | $163 | $205 | $156 |
Gross Profit | 165 | 58 | 103 | 53 |
EBITDA | -12,500 | -12,440 | -10,831 | -10,229 |
EBIT | -12,601 | -12,545 | -10,933 | -10,332 |
Net Income | -11,855 | -11,778 | -10,011 | -9,337 |
Net Change In Cash | 165 | 163 | 205 | 156 |
Free Cash Flow | -10,456 | -9,230 | -7,820 | -7,147 |
Cash | 13,038 | 25,501 | 18,658 | 21,655 |
Basic Shares | 46,865 | 44,825 | 44,678 | 44,677 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $488 | $386 | $359 | $365 |
Gross Profit | 488 | 186 | -141 | -10,869 |
EBITDA | -45,014 | -39,666 | -28,404 | -18,839 |
EBIT | -45,412 | -39,866 | -28,904 | -19,305 |
Net Income | -41,441 | -37,506 | -27,742 | -19,279 |
Net Change In Cash | 488 | 386 | 359 | 365 |
Cost of Revenue | 4,404 | -119,038 | 120,785 | |
Free Cash Flow | -31,469 | -34,712 | -23,245 | -16,526 |
Cash | 21,655 | 16,347 | 11,943 | 130,980 |
Basic Shares | 44,677 | 43,600 | 39,030 | 20,874 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.25 |
2024-06-30 | -$0.26 |
2024-03-31 | -$0.22 |
2023-12-31 | -$0.21 |
